TCR2 THERAPEUTICS INC - COM (TCRR)

Historical Holders from Q1 2019 to Q2 2023

Symbol
TCRR
Type / Class
Equity / COM
All holders as of 30 Jun 2023
Q2 2023
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-55
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of TCR2 THERAPEUTICS INC - COM (TCRR)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2023 Q2 0 $0 -$31,451,566 0
2023 Q1 20,969,238 $31,451,776 +$76,864 $1.5 56
2022 Q4 21,177,221 $21,148,134 -$6,613,516 $0.9988 59
2022 Q3 25,026,170 $45,040,152 -$293,511 $1.8 71
2022 Q2 24,870,444 $72,123,863 -$5,908,994 $2.9 70
2022 Q1 27,112,613 $74,771,186 -$11,338,291 $2.76 86
2021 Q4 29,173,804 $135,952,961 -$21,397,465 $4.66 113
2021 Q3 31,836,157 $271,100,301 -$43,426,928 $8.51 110
2021 Q2 35,028,415 $574,817,122 -$59,217,704 $16.41 114
2021 Q1 37,274,984 $823,022,807 +$107,488,715 $22.08 124
2020 Q4 35,675,307 $1,103,430,422 +$207,367,870 $30.93 117
2020 Q3 27,421,678 $556,952,380 +$249,098,444 $20.32 80
2020 Q2 15,194,157 $233,379,227 +$14,906,263 $15.36 62
2020 Q1 14,250,530 $110,296,318 -$1,047,555 $7.74 50
2019 Q4 14,169,747 $202,346,742 +$9,508,195 $14.28 44
2019 Q3 10,128,365 $152,227,185 +$35,243,284 $15.03 40
2019 Q2 7,942,180 $113,685,116 -$1,235,865 $14.31 30
2019 Q1 7,986,285 $136,386,000 +$136,386,000 $17.43 23